Mayport »

Aurinia Pharmaceuticals shares owned by Mayport

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Mayport from 13F filings

Historical chart of Mayport investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Mayport consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Mayport

Quarter filed Position value Share count Share price at filing
2025-09-30 $174k 16k 11.05

More positions owned by Mayport

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Index Fds Extend Mkt Etf (VXF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Value Etf (VTV)
Ea Series Trust Freedom 100 Em (FRDM)
Ishares Tr Short Treas Bd (SHV)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Apple (AAPL)
Meta Platforms Cl A (META)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Mayport

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Vanguard Group
Geode Capital Management
Marshall Wace
Renaissance Technologies
Two Sigma Investments
Jacobs Levy Equity Management
Jane Street
Qube Research & Technologies
Henderson Group

View all funds holding Aurinia Pharmaceuticals